ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,658Medicare Part D Prescriptions Filled, Including Refills

Rank: 166 out of 910

$575K Total Retail Price of All Prescriptions

Rank: 124 out of 910

525 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
33% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arizona
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 525 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

13% of this provider’s 525 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 8,193 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$66 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arizona
LEVOTHYROXINE SODIUM 471 440 1 1
AMLODIPINE BESYLATE 375 375 2 4
SIMVASTATIN 293 275 3 3
WARFARIN SODIUM 265 265 4 11
LISINOPRIL 233 220 5 2
HYDROCODONE-ACETAMINOPHEN 198 168 S3 6 8
FUROSEMIDE 178 178 7 9
ZOLPIDEM TARTRATE 176 169 8 17
DONEPEZIL HCL 175 175 9 32
OMEPRAZOLE 171 158 10 5
SPIRONOLACTONE 152 150 11 66
TAMSULOSIN HCL 133 128 12 29
METOPROLOL TARTRATE 132 132 13 7
CITALOPRAM HBR 128 119 14 19
TRAMADOL HCL 118 118 15 25
PREDNISONE 106 99 16 43
POTASSIUM CHLORIDE 103 98 17 18
GABAPENTIN 102 75 18 13
LOSARTAN POTASSIUM 100 98 19 15
MELOXICAM 99 98 20 76
CIPROFLOXACIN HCL 95 88 21 48
ATENOLOL 94 94 22 10
CARVEDILOL 94 91 22 36
FLUTICASONE PROPIONATE 91 90 24 23
ACTONEL 81 67 25 102
TRIAMTERENE-HCTZ 79 78 26 39
METFORMIN HCL 77 76 27 6
CRESTOR 73 72 28 26
NAMENDA 69 69 29 57
VENLAFAXINE HCL ER 67 54 30 115
RISPERIDONE 65 64 31 67
DIOVAN 63 63 32 34
HYDROCHLOROTHIAZIDE 57 57 33 12
NEXIUM 56 56 34 93
CEPHALEXIN 55 54 35 90
SPIRIVA 55 55 35 74
SERTRALINE HCL 53 44 37 24
PAROXETINE HCL 50 50 38 50
ALENDRONATE SODIUM 50 49 38 22
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 3, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.